Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Blacks more willing to exhaust financial resources for more cancer care

April 25, 2011 8:34 pm | by EurekAlert | News | Comments

(University of Alabama at Birmingham) Blacks, Hispanics and Asians are more likely than whites to spend their life savings to extend life; preferences could inform cancer care

Pharmacists Offer Guidance on Top Over-The-Counter Medications

April 25, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, April 25, 2011 /PRNewswire-USNewswire/ -- The 2010 Pharmacy Today Over-the-Counter Product Survey , conducted by the American Pharmacists Association , reveals pharmacists believe that 81% of consumers purchase the over-the-counter (OTC) product that was recommended by their...

Mylan Launches First Generic Version of Femara® Tablets

April 25, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a...


Stephen Maturo, M.D., ear, nose and throat specialist, receives Charles Ferguson Award

April 24, 2011 9:33 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology - Head and Neck Surgery) Stephen Maturo, M.D., of Boston, Mass., will receive the first place Charles Ferguson Clinical Science Award for outstanding achievement in the field of pediatric otolaryngology for his research paper titled "Intraoperative...

Combination therapy provides hope for cure of dangerous infections of cystic fibrosis patients(2)

April 24, 2011 10:34 am | by EurekAlert | News | Comments

(McMaster University) An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

Brown & Toland Makes "Best Places to Work" List for Second Year in a Row

April 22, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, April 22, 2011 /- Brown & Toland Physicians was named one of the 50 Best Places to Work in the San Francisco Bay Area for 2011. This is the second year in a row that the physician group has earned this prestigious recognition. (Logo:...

New approach to defeating flu shows promise

April 21, 2011 9:35 pm | by EurekAlert | News | Comments

(American Thoracic Society) New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu...

Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil

April 21, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

TEMPLE, Texas, April 21, 2011 /- Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative...


Cancer Centers of North Carolina Acquires Wake Radiology Oncology Services of Cary, N.C.

April 20, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

CARY, N.C. and THE WOODLANDS, Texas, April 20, 2011 /- Cancer Centers of North Carolina (CCNC), an affiliate of the United Network of US Oncology and the first practice to offer community-based outpatient cancer care in the Triangle with locations in Raleigh, North Raleigh, Cary, Dunn and...

Mylan Launches Generic Version of Famvir® Tablets

April 20, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 20, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Famciclovir Tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir® Tablets, a treatment for herpes.   Famciclovir Tablets had...

Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis

April 19, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 19, 2011 /- Amira Pharmaceuticals, Inc. announced today that AM152, the company's lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis. Commonly referred to as IPF,...

Southern Home Medical Equipment Launches Respi-Care Respiratory Therapy Program

April 19, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LYMAN, S.C., April 19, 2011 /- Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, announced today that in response to the growing demand for specialized solutions for...

GlideScope Video Laryngoscope from Verathon Medical Canada Celebrates 10th Anniversary of Video Laryngoscopy and Improving Patient Care

April 18, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., April 18, 2011 /- The GlideScope® video laryngoscope, invented by Canadian vascular surgeon Dr. Jack Pacey and manufactured in Vancouver, B.C., is celebrating its tenth anniversary in 2011.  A celebration will be held on April 21st at the company's new...


Study Finds Exergen Temporal Artery Thermometry Accurate on Newborns

April 18, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WATERTOWN, Mass., April 18, 2011 /- Measuring the body temperatures of newborns with temporal artery thermometry (forehead scanning) provides readings comparable to results obtained by axillary (under arm) thermometry, the clinically recommended method for this patient population, but...

Bedford Laboratoriesâ„¢ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial

April 18, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Ohio,  April 18, 2011 /- Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Topotecan Hydrochloride for Injection, 4 mg (base)/vial to its diverse portfolio.  Topotecan is AP Bioequivalent to the reference...

La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders

April 17, 2011 10:33 am | by EurekAlert | News | Comments

(La Jolla Institute for Allergy and Immunology) Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising...

ERT Reports First Quarter 2011 Operating Results on May 2, 2011

April 15, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, April 15, 2011 /- ERT (Nasdaq: ERES ) announced today that it will release its operating results for the first quarter 2011 Monday, May 2, after the market closes. After the release, the Company will host a conference call at 5:00 PM ET that day. For the conference call,...

Safety of stored blood among chief concerns for transfusion medicine community

April 14, 2011 9:33 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) In light of recent studies that suggest the use of stored blood during transfusions may cause adverse effects in patients, the National Heart, Lung, and Blood Institute funded a number of research projects to examine the safety of transfusing older red cells and the...

Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting

April 14, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 14, 2011 /- New results from the largest multicenter clinical trial for heart transplant patients will be released this week at the International Society for Heart & Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions in San Diego.  Results...

ERT Awarded over $10 Million of ePRO Business from Major Pharma – Increasing its Position as a Leading ePRO Provider

April 14, 2011 7:33 am | by RealWire | News | Comments

PHILADELPHIA, PA - 14 April 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that it was awarded three new contracts with top tier pharmaceutical companies, totaling over...

Mpex Pharmaceuticals, Inc. to be Acquired by Axcan

April 14, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 14, 2011 /- Mpex Pharmaceuticals, Inc. announced today that Axcan and Mpex have entered into agreements pursuant to which Axcan will acquire all of the outstanding shares of Mpex and its lead product candidate, Aeroquin™.  A proprietary aerosol formulation of...

Congress Must Maintain Commitment to Advanced Biofuels and Renewable Fuel Standard, BIO Says

April 14, 2011 5:34 am | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Wednesday, April 13, 2011) - The Renewable Fuel Standard provides the market and regulatory certainty necessary to drive private investment and maintain progress in research and development of advanced biofuels, the Biotechnology Industry Organization (BIO) said today in...

Tissue Engineering Shows Promise to Revolutionize Transplant Medicine

April 13, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 13, 2011 /- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.  While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at...

Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations

April 13, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

CENTENNIAL, Colo., April 13, 2011 /- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek...

MSA Schedules First Quarter Earnings Webcast

April 12, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 12, 2011 /- MSA (NYSE: MSA ), the global leader in the development, manufacture and supply of products that protect people's health and safety, announced today that it will broadcast a first quarter 2011 earnings conference call live via the Internet on Thursday, April...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.